Synalloy Cp (SYNL) 8.88 $SYNL 21.0% Return Seen to Date

New Post Public Reply Private Reply Replies (0) Message Board

Sep 24, 2016 at 5:13 AM

Synalloy Cp (SYNL) 8.88 $SYNL

21.0% Return Seen to Date on SmarTrend Synalloy Call (SYNL)
Comtex SmarTrend(R) - Thu Sep 22, 1:25AM CDT
SmarTrend identified an Uptrend for Synalloy (NASDAQ:SYNL) on September 7th, 2016 at $7.66. In approximately 2 weeks, Synalloy has returned 20.97% as of today's recent price of $9.26.
SYNL: 8.88 (-0.09)

Synalloy Closes on ABL Credit Facility for $45.0 Million and Signs Purchase and Sale Agreement on Sale-Leaseback for $22.0 Million with Closing Expected October 2016
GlobeNewswire - Thu Sep 01, 2:59PM CDT
Synalloy Corporation (Nasdaq:SYNL) today announced the closing of a new asset based ("ABL"

credit facility with its bank, Branch Banking and Trust Company ("BB&T"

, and its entrance into a purchase and sale agreement for sale-leaseback of its real estate properties in Tennessee, South Carolina, Texas and Ohio.
SYNL: 8.88 (-0.09)

Synalloy Reports Second Quarter 2016 Results: Weak Economic Fundamentals Drive Depressed Sales and Profits - Lowered Expectations for Full Year 2016
GlobeNewswire - Tue Aug 09, 6:00AM CDT
Synalloy Corporation (Nasdaq:SYNL), today announced net sales for the second quarter of 2016 of $34.9 million. This represents a decrease of $15.3 million or 30% when compared to net sales for the second quarter of 2015. Net sales for the first six months of 2016 were $71.2 million, down $30.6 million or 30% from 2015.
SYNL: 8.88 (-0.09)

Synalloy Announces Second Quarter Earnings Conference Call
GlobeNewswire - Mon Aug 01, 12:00PM CDT
Synalloy Corporation (Nasdaq:SYNL) plans to announce its second quarter 2016 earnings results in a press release that will be issued before the market opens on Tuesday, August 9, 2016. Following the earnings release, Synalloy will conduct a conference call and webcast at 9:00 AM EDT to discuss the earnings results. Interested parties may listen to this discussion by calling 1 (877) 303-6648; Conference ID code 59714842. The conference call will be webcast live through Synalloy's website at www.synalloy.com under the Investor Relations tab.
SYNL: 8.88 (-0.09)

MRC Global's Growth Prospects Bright Despite Macro Risks
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 9:34AM CDT
On Jun 7, 2016, we issued an updated research report on MRC Global Inc. (MRC).
AG: 11.25 (-0.71), MRC: 14.54 (-0.08), SYNL: 8.88 (-0.09), AGFS: 5.32 (-0.16)

Synalloy (SYNL) Sees Hammer Chart Pattern: Time to Buy?
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 10:07AM CDT
Synalloy Corporation (SYNL) has been struggling lately, but the selling pressure may be coming to an end soon
SYNL: 8.88 (-0.09)

Synalloy reports 1Q loss
Automated Insights - Mon May 09, 7:20AM CDT
RICHMOND, Va. (AP) _ Synalloy Corp. (SYNL) on Monday reported a first-quarter loss of $1.4 million, after reporting a profit in the same period a year earlier.
SYNL: 8.88 (-0.09)

Synalloy Reports First Quarter 2016 Results: Continued Negative Impact from Oil & Gas Industry Declines and Nickel Metal Pricing
GlobeNewswire - Mon May 09, 6:00AM CDT
Synalloy Corporation (Nasdaq:SYNL), today announced net sales for the first quarter of 2016 of $36.3 million. This represents a decrease of $15.3 million or 30% when compared to net sales for the first quarter of 2015.
SYNL: 8.88 (-0.09)

Synalloy Announces First Quarter Earnings Conference Call
GlobeNewswire - Mon May 02, 12:59PM CDT
Synalloy Corporation (Nasdaq:SYNL), plans to announce its first quarter 2016 earnings results in a press release that will be issued before the market opens on Monday, May 9, 2016. Following the earnings release, Synalloy will conduct a conference call and webcast at 9:00 AM EDT to discuss the earnings results. Interested parties may listen to this discussion by calling 1 (877) 303-6648; Conference ID code 1689514. The conference call will be webcast live through Synalloy's website at www.synalloy.com under the Investor Relations tab.
SYNL: 8.88 (-0.09)

Synalloy Has Returned 13.8% Since SmarTrend Recommendation (SYNL)
Comtex SmarTrend(R) - Tue Feb 02, 3:39PM CST
SmarTrend identified a Downtrend for Synalloy (NASDAQ:SYNL) on November 12th, 2015 at $8.13. In approximately 3 months, Synalloy has returned 13.85% as of today's recent price of $7.00.
SYNL: 8.88 (-0.09)

POSCO Posts 2015 Loss on Valuation & Subsidiary Woes
Zacks Equity Research - Zacks Investment Research - Fri Jan 29, 10:35AM CST
POSCO (PKX) reported disappointing results for 2015, with net loss of KRW 96 billion ($0.08 billion) versus net earnings of KRW 557 billion (KRW 0.53 billion) recorded in 2014.
SIM: 8.68 (-0.24), AKS: 4.96 (+0.18), SYNL: 8.88 (-0.09), PKX: 50.57 (-0.15)

Technical Data Tells the Change in Tide - Consensus Reports on Companhia Brasileira de Distribuicao, Fuchs Petrolub, Synalloy, and WSI Industries
ACCESSWIRE - Fri Jan 29, 7:15AM CST
NEW YORK, NY / ACCESSWIRE / January 29, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Companhia Brasileira de Distribuicao (NYSE: CBD), Fuchs Petrolub SE (OTC: FUPBY), Synalloy Corp. (NASDAQ: SYNL) and WSI Industries Inc. (NASDAQ: WSCI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
SYNL: 8.88 (-0.09), WSCI: 3.50 (+0.12), CBD: 17.22 (+0.47)

Synalloy Down 17.5% Since SmarTrend Downtrend Call (SYNL)
Comtex SmarTrend(R) - Fri Jan 22, 5:25PM CST
SmarTrend identified a Downtrend for Synalloy (NASDAQ:SYNL) on November 12th, 2015 at $8.13. In approximately 2 months, Synalloy has returned 17.54% as of today's recent price of $6.70.
SYNL: 8.88 (-0.09)

MRC Global Slips to Sell on Pricing and Headwind Woes
Zacks Equity Research - Zacks Investment Research - Tue Jan 19, 1:10PM CST
On Jan 18, 2015, Zacks Investment Research downgraded MRC Global Inc. (MRC) to a Zacks Rank #4 (Sell) from a Zacks Rank #3 (Hold).
AEM: 54.33 (-2.22), MRC: 14.54 (-0.08), VMI: 130.63 (-3.37), SYNL: 8.88 (-0.09)

Shiloh (SHLO) Reports Q4 Loss, Projects Soft Q1 Conditions
Zacks Equity Research - Zacks Investment Research - Fri Jan 15, 8:50AM CST
Shiloh Industries Inc. (SHLO) reported lackluster results for both fourth-quarter and fiscal year 2015 (ended Oct 31, 2015). In the quarter, the company???s bottom line dipped to a loss of 5 cents per share (on an adjusted basis) from a break-even situation in the prior-year quarter.
SIM: 8.68 (-0.24), SHLO: 7.06 (-0.02), SYNL: 8.88 (-0.09), PPG: 103.27 (+0.13)

Synalloy Shares Down 19.0% Since SmarTrend's Sell Call (SYNL)
Comtex SmarTrend(R) - Thu Jan 14, 7:35PM CST
SmarTrend identified a Downtrend for Synalloy (NASDAQ:SYNL) on November 12th, 2015 at $8.13. In approximately 2 months, Synalloy has returned 19.02% as of today's recent price of $6.58.
SYNL: 8.88 (-0.09)

Gerdau's Exposure to Risks Overshadows Future Prospects
Zacks Equity Research - Zacks Investment Research - Thu Jan 14, 2:00PM CST
We issued an updated research report on Gerdau S.A. (GGB) on Jan 13, 2016.
GGB: 2.67 (unch), SIM: 8.68 (-0.24), SYNL: 8.88 (-0.09), PPG: 103.27 (+0.13)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...